冠状动脉旁路移植术与自体冠状动脉疾病活动性
本研究纳入293例确诊冠状动脉疾病患者,基线行18F-氟化钠PET、冠状动脉钙化评分及冠状动脉CT血管成像,1年后重复钙化评分,比较移植与未移植自体冠状动脉的微钙化活动与钙化进展。结果显示旁路移植的自体冠状动脉微钙化活动约为未移植者的3倍,1年钙化进展更明显;移植血管本身微钙化活动不突出。
要点
- 旁路移植的自体冠状动脉微钙化活动约为未移植者的3倍,且1年钙化进展更明显。
- 移植血管中仅8根大隐静脉桥在7例受试者中可检测到微钙化活动,所有动脉桥及多数静脉桥无18F-氟化钠摄取。
- 旁路移植的自体冠状动脉疾病活动增强与基线斑块负荷无关,效应主要局限于吻合口近端的自体冠状动脉斑块。
核心结论
- 旁路移植的自体冠状动脉较未移植者疾病活动性增高、进展更快,该观察似乎独立于基线动脉粥样硬化斑块负荷;微钙化活动不是移植血管病变的主要特征。
研究设计与样本
- 研究论文;293例确诊冠状动脉疾病患者,基线行18F-氟化钠PET、冠状动脉钙化评分及冠状动脉CT血管成像,1年后重复钙化评分;48例(16%)既往接受冠状动脉旁路移植术,中位时间2.7年(IQR 1.4-10.4年);另设48例匹配的未移植患者进行敏感性分析。
关键影像表现/征象
- 全部动脉桥及128根静脉桥中的120根(94%)未见18F-氟化钠摄取,7例受试者的8根大隐静脉桥可检测到微钙化活动。
诊断标准与关键数值
- 旁路移植的自体冠状动脉微钙化活动为2.1(IQR 0.4-7.5),未移植者为0.6(IQR 0-2.7),P<0.001;1年钙化评分进展分别为118 Agatston单位(IQR 48-194)与69 Agatston单位(IQR 21-142),P=0.01;敏感性分析中旁路移植的自体冠状动脉微钙化活动为2.0(IQR 0.4-7.5) vs 匹配未移植者0.8(IQR 0.3-3.2),P<0.001,疾病进展为24%(IQR 16%-43%) vs 8%(IQR 0%-24%),P=0.002。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to describe the potential of 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) to identify graft vasculopathy and to investigate the influence of coronary artery bypass graft (CABG) surgery on native coronary artery disease activity and progression.
BACKGROUND: As well as developing graft vasculopathy, CABGs have been proposed to accelerate native coronary atherosclerosis.
METHODS: Patients with established coronary artery disease underwent baseline 18F-NaF PET, coronary artery calcium scoring, coronary computed tomographic angiography, and 1-year repeat coronary artery calcium scoring. Whole-vessel coronary microcalcification activity (CMA) on 18F-NaF PET and change in calcium scores were quantified in patients with and without CABG surgery.
RESULTS: Among 293 participants (mean age 65 ± 9 years, 84% men), 48 (16%) underwent CABG surgery 2.7 years [IQR: 1.4-10.4 years] previously. Although all arterial and the majority (120 of 128 [94%]) of vein grafts showed no 18F-NaF uptake, 8 saphenous vein grafts in 7 subjects had detectable CMA. Bypassed native coronary arteries had 3 times higher CMA values (2.1 [IQR: 0.4-7.5] vs 0.6 [IQR: 0-2.7]; P < 0.001) and greater progression of 1-year calcium scores (118 Agatston unit [IQR: 48-194 Agatston unit] vs 69 [IQR: 21-142 Agatston unit]; P = 0.01) compared with patients who had not undergone CABG, an effect confined largely to native coronary plaques proximal to the graft anastomosis. In sensitivity analysis, bypassed native coronary arteries had higher CMA (2.0 [IQR: 0.4-7.5] vs 0.8 [IQR: 0.3-3.2]; P < 0.001) and faster disease progression (24% [IQR: 16%-43%] vs 8% [IQR: 0%-24%]; P = 0.002) than matched patients (n = 48) with comparable burdens of coronary artery disease and cardiovascular comorbidities in the absence of bypass grafting.
CONCLUSIONS: Native coronary arteries that have been bypassed demonstrate increased disease activity and more rapid disease progression than nonbypassed arteries, an observation that appears independent of baseline atherosclerotic plaque burden. Microcalcification activity is not a dominant feature of graft vasculopathy.
引用
- Kwiecinski, Tzolos, Fletcher, et al. Bypass Grafting and Native Coronary Artery Disease Activity. JACC Cardiovasc Imaging. 2022. PMID: 35216930. doi:10.1016/j.jcmg.2021.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。